Bosentan (under the brand name Tracleer by Actelion Pharmaceuticals) is the first approved endothelian receptor antagonist. It was approved by the FDA in November 2001 and is used in the treatment of Pulmonary Arterial Hypertension.- Category ID : 78899
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations